The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126818112 12681811 2 F 20151217 20160822 20160824 20160829 EXP US-GILEAD-2016-0229274 GILEAD 0.00 YR N F Y 1.05000 KG 20160829 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126818112 12681811 1 PS EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINETENOFOVIR DISOPROXIL 1 Transplacental 1 DF, QD 21752 1 DF TABLET QD
126818112 12681811 2 SS TIVICAY DOLUTEGRAVIR SODIUM 1 Transplacental 50 MG, QD 2800 MG 0 50 MG QD
126818112 12681811 3 SS REYATAZ ATAZANAVIR SULFATE 1 Transplacental 300 MG, QD 0 300 MG QD
126818112 12681811 4 SS NORVIR RITONAVIR 1 Transplacental 100 MG, QD 0 100 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126818112 12681811 1 HIV infection
126818112 12681811 2 HIV infection
126818112 12681811 3 HIV infection
126818112 12681811 4 HIV infection

Outcome of event

Event ID CASEID OUTC COD
126818112 12681811 CA
126818112 12681811 OT
126818112 12681811 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126818112 12681811 Foetal exposure during pregnancy
126818112 12681811 Patent ductus arteriosus
126818112 12681811 Premature baby

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126818112 12681811 1 20160620 0
126818112 12681811 2 20160425 20160620 0